Planning for Pandemic Influenza: Lessons from the Experiences of Thirteen Indiana Counties

Significant concerns exist over the ability of the healthcare and public health systems to meet the surge demands that would result from an event such as an influenza pandemic. Current guidance for public health planners is largely based on expert opinion and may lack connection to the problems of street-level public health practice. To identify the problems of local planners and prepare a state-level planning template for increasing health care surge capacity that accounted for these issues,a study was conducted of local pandemic planning efforts in thirteen counties, finding that cognitive biases, coordination problems, institutional structures in the healthcare system, and resource shortfalls are significant barriers to preparing and implementing a surge capacity plan. In addition, local planners identify patient demand management through triage and education efforts as a viable means of ensuring adequate capacity, in contrast to guidance proposing an increased supply of care as a primary tool

Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry : the ABRF glycoprotein research multi-institutional study 2012

One of the principal goals of glycoprotein research is to correlate glycan structure and function. Such correlation is necessary in order for one to understand the mechanisms whereby glycoprotein structure elaborates the functions of myriad proteins. The accurate comparison of glycoforms and quantification of glycosites are essential steps in this direction. Mass spectrometry has emerged as a powerful analytical technique in the field of glycoprotein characterization. Its sensitivity, high dynamic range, and mass accuracy provide both quantitative and sequence/structural information. As part of the 2012 ABRF Glycoprotein Research Group study, we explored the use of mass spectrometry and ancillary methodologies to characterize the glycoforms of two sources of human prostate specific antigen (PSA). PSA is used as a tumor marker for prostate cancer, with increasing blood levels used to distinguish between normal and cancer states. The glycans on PSA are believed to be biantennary N-linked, and it has been observed that prostate cancer tissues and cell lines contain more antennae than their benign counterparts. Thus, the ability to quantify differences in glycosylation associated with cancer has the potential to positively impact the use of PSA as a biomarker. We studied standard peptide-based proteomics/glycomics methodologies, including LC-MS/MS for peptide/glycopeptide sequencing and label-free approaches for differential quantification. We performed an interlaboratory study to determine the ability of different laboratories to correctly characterize the differences between glycoforms from two different sources using mass spectrometry methods. We used clustering analysis and ancillary statistical data treatment on the data sets submitted by participating laboratories to obtain a consensus of the glycoforms and abundances. The results demonstrate the relative strengths and weaknesses of top-down glycoproteomics, bottom-up glycoproteomics, and glycomics methods.17 page(s